4 purchases reported after at least 12 months of silence — most recent on 23 Jul 2025.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AlzeCurePharma | 2,044,522 | net | 23 Jul 2025 | tx 10+2,594,522−550,000 |
| First North | 80,000 | net | 02 Dec 2020 | tx 1+80,000 |
| Bio-Works Technologies AB | 15,000 | net | 29 Jun 2018 | tx 1+15,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Jul 2025 | PURCHASE | AlzeCurePharma | 568,030 | 2.20 SEK | first after silence |
| 17 May 2024 | PURCHASE | AlzeCurePharma | 429,813 | 1.70 SEK | |
| 17 May 2024 | PURCHASE | AlzeCurePharma | 320,833 | 1.70 SEK | first after silence |
| 21 Dec 2022 | PURCHASE | AlzeCurePharma | 60,896 | 3.75 SEK |
| 22 Dec 2022 | PURCHASE | AlzeCurePharma | 205,770 | 3.75 SEK |
| 17 Mar 2022 | PURCHASE | AlzeCurePharma | 352,750 | 4.00 SEK | first after silence |
| 17 Mar 2022 | PURCHASE | AlzeCurePharma | 550,000 | 0.00 SEK | deriv |
| 17 Mar 2022 | SALE | AlzeCurePharma | 550,000 | 0.00 SEK | deriv |
| 02 Dec 2020 | PURCHASE | First North | 80,000 | 9.16 SEK | first after silence |
| 18 Jun 2019 | PURCHASE | AlzeCurePharma | 35,000 | 0.70 SEK | derivanomaly |
| 20 Nov 2018 | PURCHASE | AlzeCurePharma | 71,430 | 14.00 SEK |
| 29 Jun 2018 | PURCHASE | Bio-Works Technologies AB | 15,000 | 0.88 SEK | anomaly |